Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 79
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security Appendixes
OCR for page 80
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security This page intentionally left blank.
OCR for page 81
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security Appendix A Committee Biographies David Franz, Chair, is chief biological scientist at the Midwest Research Institute. He served in the U.S. Army Medical Research and Materiel Command for 23 of his 27 years on active duty. Dr. Franz has served as both deputy commander and then commander of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and as deputy commander of the U.S. Army Medical Research and Materiel Command. Prior to joining the Command, he served as group veterinarian for the 10th Special Forces Group (Airborne). Dr. Franz served as chief inspector on three United Nations Special Commission biological warfare inspection missions to Iraq and as technical advisor on long-term monitoring missions. He also served as a member of the first two U.S./U.K. teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons and as a member of the Trilateral Experts Committee for biological weapons negotiations. David Ashford is an epidemiologist with the National Center for Environmental Health (NCEH) at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. In this position, he coordinates branch epidemiological studies on public health preparedness against terrorism. He also acts as an NCEH contact point for biological terrorism preparedness, anthrax vaccine issues, and surveillance. Dr. Ashford received his DVM from Cornell University in 1986, and his Masters in Public Health and Doctorate in Science from Harvard University in 1989 and 1996 respectively. He is author of 60 articles related to zoonotic diseases and public health and 15 textbook chapters.
OCR for page 82
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security Carol Blair is a professor of microbiology at Colorado State University. Previously, Dr. Blair served as the assistant dean for biomedical sciences, associate dean for undergraduate education, and head of the microbiology department. Before joining the faculty at Colorado State University, Dr. Blair was a lecturer in microbiology at Trinity College in Dublin, Ireland, for five years. She received her Ph.D. in molecular biology from the University of California, Berkeley, and is a member of numerous scientific and academic associations, including: Phi Beta Kappa; Phi Kappa Phi; Sigma Xi; American Society for Microbiology; American Society for Virology (ASV); Society for General Microbiology; American Society of Tropical Medicine and Hygiene (ASTMH); and American Association for Advancement of Science (AAAS). Dr. Blair has served as a council member for the ASV and AAAS, and as chair of the American Committee on Arthropod-borne Viruses of the ASTMH. Gail Cassell is vice president for scientific affairs, and distinguished Lilly research scholar for infectious disease at Eli Lilly and Company, Lilly Corporate Center. She has received a number of awards for her research in infectious diseases, including an honorary degree, and is a recent past president of the American Society of Microbiology. She has been active in national and international policy deliberations, including those of the National Institutes of Health (NIH) and the U.S.-Japan Cooperative Medical Science Program. She is also a member of the steering committee of the U.S.-Japan Cooperative Medical Sciences Program. She is a recent chair of the Board of Scientific Counselors of the National Center for Infectious Diseases of the CDC and a member of the Advisory Committee to the Director of CDC and the Director of NIH. She currently is a member of the Secretary of Health and Human Services Advisory Council for Public Health Preparedness. She is also a member of the Institute of Medicine (IOM). Maurice Hilleman was director of Merck Institute and was formerly senior vice president of Merck Research Laboratories, West Point, Pennsylvania. He was also adjunct professor of pediatrics, University of Pennsylvania. His career included service in basic and applied agencies including the Department of Health and Human Services, World Health Organization (WHO), Overseas Medical Research Laboratory Committee of the Department of Defense, and special committees of the National Academies of Science and the Institute of Medicine. Dr. Hilleman was instrumental in the development of vital vaccines such as those for mumps and pandemic flu. In addition, he was very active in broader scientific work aimed at serving the international scientific community and giving back to society. Dr. Hilleman received his Ph.D. from the University of Chicago, held four honorary degrees, and was a member of the National Academies of Science (NAS) and the IOM. Dr. Hilleman remained involved in the process of producing this study until his death on April 11, 2005.
OCR for page 83
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security Christopher P. Howson is vice-president for global programs at the March of Dimes. Formerly, he was Director of the Board on International Health of the IOM. In his 12 years at the NAS/IOM, he directed 15 projects and in 1993 served as acting director of the IOM Medical Follow-up Agency. Before coming to NAS, he was senior epidemiologist at the American Health Foundation in New York City. He holds a Ph.D. in epidemiology from the University of California, Los Angeles. Peter B. Jahrling is scientific adviser and senior research scientist at USAMRIID. He is head of the WHO collaborating center on arbovirus and hemorrhagic fever virus research at USAMRIID, and a member of the Committee on the Return of Biological Samples of the National Research Council, CDC/NIH guest editor for the 3rd and 4th editions of Biosafety in Microbiological and Biomedical Laboratories, and chairman of the Subcommittee on Laboratory Safety at the American Committee on Arthropod-borne Viruses. Paul Keim is the Cowden Endowed Chair in Microbiology at Northern Arizona University and director of Pathogen Genomics at the Translational Genomics Research Institute (TGen). His current research interest includes genomic analysis of bacterial pathogens. His laboratory has developed high resolution strain typing analysis methods for B. anthracis, Y. pestis, and F. tularensis. Several collaborative projects are currently underway with scientists from the former Soviet Union to understand the ecology and epidemiology of these pathogens. He currently holds research funding from NIH, the Department of Homeland Security, the Federal Bureau of Investigation, and the National Science Foundation that supports a laboratory of about 40 researchers. He has served on grant review panels for the U.S. Department of Agriculture (USDA) and NIH. He has published 150 peer-reviewed journal articles. He is a Laboratory Affiliate at Los Alamos National Laboratory. James LeDuc is the director of the Division of Viral and Rickettsial Diseases in the National Center for Infectious Diseases, CDC. His professional career began as a field biologist working with the Smithsonian Institution’s African Mammal Project in West Africa. Following that he served for 23 years as an officer with the United States Army Medical Research and Development Command. He joined CDC in 1992 and was assigned to the WHO as a Medical Officer, later becoming the Associate Director for Global Health at the National Center for Infectious Diseases (NCID). His research interests include epidemiology of arboviruses and viral hemorrhagic fevers, and global health. Matthew Meselson is Thomas Dudley Cabot Professor of Natural Sciences at Harvard University and co-director of the Harvard-Sussex program on chemical and biological warfare armament and arms limitation. He has conducted research
OCR for page 84
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security mainly in the field of molecular genetics and is recipient of the NAS Award in Molecular Biology, the Eli Lilly Award in Microbiology, the Thomas Hunt Morgan Medal of the Genetics Society of America, and the Laskev Award for Special Achievement in Medical Science. He is a member of the Royal Society, the Academie des Sciences, the Russian Academy of Sciences, and the NAS. He has served as a consultant on chemical and biological weapons matters to U.S. government agencies. Rebecca Morton is a professor in the department of veterinary pathobiology at Oklahoma State University (OSU). She is a diplomat of the American College of Veterinary Microbiologists and has served as head of the Microbiology Section of the Oklahoma Animal Disease Diagnostic Laboratory. She has twice received the OSU Regents Distinguished Award for the development and implementation of infectious disease courses for veterinary medical students. Her current research interest is tularemia and she is working with Baylor College of Medicine in the sequencing and annotation Francisella tularensis strains and the determination of virulence factors for vaccine development. She has also been active in screening drugs against biological threat agents and developing and testing of biosensors for the detection of biological agents. Frederick A. Murphy is a professor at the School of Veterinary Medicine at the University of California, Davis. Formerly, he was dean of the school and earlier he was director of the NCID at CDC. He is a member of the IOM and of the NAS. He is a recipient of the Presidential Rank Award and is a member of the German Academy of Natural Sciences. He has been a leader in research on viral pathogenesis, viral characterization, and viral taxonomy; his interests include public health policy, comparative medicine, and new, emerging, and reemerging diseases. Joseph Silva is dean of the School of Medicine at the University of California, Davis. Previously, Dr. Silva served as chair of the Internal Medicine Department. He received his MD from Northwestern University Medical School (Illinois). His internship and residency training were undertaken at Johns Hopkins Hospital and a fellowship in infectious diseases was completed at the University of Michigan Medical School. After serving two years in the U.S. Air Force, Silva returned to the University of Michigan, where he was appointed assistant professor of internal medicine in the division of infectious diseases before he joined UC Davis in 1983. He is a renowned clinician, with specialty and research interests in bacterial diseases. He is a physician who speaks Russian and has great credibility in infectious diseases that extends beyond those associated with biological weapons. He is on the Board of Regents of the American College of Physicians and was formerly governor of the Northern California Chapter.
OCR for page 85
Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security Richard Witter is a collaborator at the USDA-Agricultural Research Service Avian Disease and Oncology Laboratory. His discoveries have contributed significantly to the control of Marek’s disease, a virus-induced cancer of poultry, by vaccination. Marek’s disease was the most costly poultry disease worldwide, and his achievements were the first example of practical control of neoplastic disease by vaccination. Dr. Witter is a member of the NAS. Russ Zajtchuk is professor emeritus in the Department of Surgery at Rush University Hospitals. He is also Chief Executive Officer of Chicago Hospitals International, LLC. Dr. Zajtchuk received all his medical training at the University of Chicago. He spent 28 years in the U.S. Army; his last position in the army was as Commanding General of U.S. Army Medical Research and Materiel Command. Upon retirement from the army he spent five years at Rush University as Vice President for Advanced Technologies and International Health.
Representative terms from entire chapter: